2型糖尿病患者下肢动脉硬化的影响因素及治疗效果分析

首都医科大学学报 ›› 2007, Vol. 28 ›› Issue (5): 636-639.

2型糖尿病患者下肢动脉硬化的影响因素及治疗效果分析

刘薇, 付汉菁, 杨金奎, 杜燕芳

首都医科大学附属北京同仁医院内分泌科

收稿日期:2007-03-12 修回日期:1900-01-01 出版日期:2007-10-24 发布日期:2007-10-24

Arteriosclerosis in Lower Extremity Complicated with Type 2 Diabetes Mellitus-Risk Factors and the Therapeutic Effect

Liu Wei, Fu Hanjing, Yang Jinkui, Du Yanfang

Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University

Received:2007-03-12 Revised:1900-01-01 Online:2007-10-24 Published:2007-10-24

摘要/Abstract

摘要： 目的探讨2型糖尿病患者不同程度下肢动脉硬化与传统动脉硬化危险因素、代谢控制状况的关系,以及对前列腺素E治疗的反应。方法选取近2年住院的2型糖尿病患者168例,采用多普勒血流测定仪进行下肢动脉节段性测压(踝/臂指数ABI),比较不同程度下肢动脉硬化患者胰岛功能、代谢控制状况及动脉硬化的相关危险因素,同时所有患者经前列腺素E(凯时)治疗10～14d后复查ABI,比较其治疗前后的变化。结果全体患者根据ABI测定结果分为无下肢动脉硬化组(ABI>1),轻-中度下肢动脉硬化组(1>ABI>0.5),重度下肢动脉硬化组(ABI<0.5)共3组,结果发现:重度下肢动脉硬化组24h血压监测最低舒张压明显低于其他2组,差异有统计学意义(P<0.05),超声心动图显示射血分数在轻-中度动脉硬化组明显高于其他2组,差异有统计学意义(P<0.05),尿白蛋白排泄率(UAER)在中度下肢动脉硬化组明显高于无下肢动脉硬化组(P<0.05),且与下肢动脉硬化程度呈正相关(r分别为0.288、0.361、0.544,P值分别为0.036、0.001、0.001)。此外,年龄、病程、基础C肽、糖化血红蛋白、血脂水平在合并下肢动脉硬化组均高于无下肢动脉硬化组,但差异无统计学意义。前列腺素E治疗后各组ABI水平与治疗前比较均有不同程度升高,但治疗前后差异无统计学意义。结论下肢节段性测压是发现和评价动脉硬化程度的简便有效手段,通过HDL(高密度脂蛋白)可以推断ABI的预测值,尿白蛋白排泄率与下肢动脉硬化发生有密切联系,前列腺素E治疗对改善ABI水平有效。

关键词: 2型糖尿病, 下肢动脉硬化, 踝/臂指数

Abstract: Objective To investigate the effect of metabolic control and different risk factors of arteriosclerosis in lower extremity complicated with type 2 diabetes mellitus, and the therapeutic efficacy of PGE1.Methods One hundred and sixty-eight hospitalized patients with type 2 diabetes mellitus in the recent two years were enrolled in our study. We observed the ABI level through the Hunt Leigh Doppler manometry, and compared the risk factors such as the function of pancreatic island, metabolic control etc. Among the diabetics with macro-vascular complications, a therapy of Lipo prostaglandin E₁(PGE1) was installed in all patients whose ABI were lower than 1 for 10 to 14 days, and then the ABI levels were observed again. All subjects in our study were divided into three sub-groups based on their ABI, they are group A: ABI>1, group B: 1>ABI>0.5, group C: ABI<0.5.Results The results of 24 h monitoring of blood pressure showed that the Min-DBP in group C was significantly lower than that in group A and B, the P-values were 0.047 and 0.010 respectively. In UCG, the level of EF in group B was significantly higher than those in group A and C, the P-values were 0.006 respectively and 0.005 respectively. The level of UAER in group B was significantly higher than that in group A, P=0.22. Univariate analyses showed that in all lower ABI patients, age at examination, duration of diabetes, C-peptide level, total cholesterol and LDL cholesterol, glycosylated hemoglobin A1c, urinary albumin excretion rate(UAER) were higher than those who had normal ABI, although the difference was not significant. Multivariate analyses showed that UAER was positively related to ABI. After the PGE₁ therapy for 10 or 14 days, the ABI levels were all higher than the baseline, but difference was not significant.Conclusion ABI level is effective in evaluatin g the arteriosclerosis in lower extremity in type 2 diabetes. We can deduce the ABI level by HDL cholesterol. PGE1 can improve the ABI level of chronic arterial ischemia of legs.

Key words: type 2 diabetes mellitus, arteriosclerosis in lower extremity, the ankle/brachial index

中图分类号:

R587.1

刘薇;付汉菁;杨金奎;杜燕芳. 2型糖尿病患者下肢动脉硬化的影响因素及治疗效果分析[J]. 首都医科大学学报, 2007, 28(5): 636-639.

Liu Wei;Fu Hanjing;Yang Jinkui;Du Yanfang. Arteriosclerosis in Lower Extremity Complicated with Type 2 Diabetes Mellitus-Risk Factors and the Therapeutic Effect[J]. Journal of Capital Medical University, 2007, 28(5): 636-639.

[1]	苏志燕, 刘薇, 史婷婷. 老年2型糖尿病患者血尿酸浓度与代谢综合征的相关性分析[J]. 首都医科大学学报, 2023, 44(1): 137-142.
[2]	马艺欣, 张仲迎, 佀思聪, 罗鸿宇, 赵欢, 杨伟. 2型糖尿病患者新型脂肪因子血清内脏脂肪素和内脏脂肪特异性丝氨酸蛋白酶抑制因子的表达水平与左心室肥厚的关系[J]. 首都医科大学学报, 2022, 43(5): 767-773.
[3]	修双玲, 付俊玲, 穆志静, 孙丽娜, 赵蕾. 老年2型糖尿病患者体脂率对肌力和躯体功能的影响[J]. 首都医科大学学报, 2022, 43(4): 641-646.
[4]	宋丽敏, 李思源, 李军, 赵会荣, 李佳佳, 王双. 新疆石河子地区绝经后2型糖尿病女性SOST基因联合LRP5基因多态性及突变与骨代谢关系的研究[J]. 首都医科大学学报, 2022, 43(2): 269-274.
[5]	修双玲, 孙丽娜, 穆志静, 付俊玲, 赵蕾. 不同方法校正的肌肉质量与老年2型糖尿病躯体功能的相关性比较[J]. 首都医科大学学报, 2022, 43(2): 284-288.
[6]	杨柳青, 田红梅, 石汉平. 三种饮食模式与慢性疾病研究进展[J]. 首都医科大学学报, 2022, 43(2): 311-320.
[7]	张冬雪, 文祯, 孙玉燕, 姜涛. 初诊2型糖尿病患者中肝脏胰岛素清除率与临床特点及胃肠激素相关性的初步分析[J]. 首都医科大学学报, 2021, 42(5): 822-828.
[8]	米颖馨, 王欣, 张开, 李可悦, 孙丽娜, 修双玲. 中老年男性2型糖尿病患者尿酸水平与肌少症的相关性研究[J]. 首都医科大学学报, 2021, 42(3): 453-458.
[9]	郑爽爽, 高志远, 宋双双, 何悦明, 卢洁. BOLD MRI评价糖尿病患者尿微量白蛋白及氧合水平的研究[J]. 首都医科大学学报, 2021, 42(1): 125-130.
[10]	李响, 蒲连美, 阮杨, 李红, 金泽宁. 汉族人群ADIPOR1 rs7539542与冠状动脉粥样硬化性心脏病和2型糖尿病的关联分析[J]. 首都医科大学学报, 2020, 41(6): 935-942.
[11]	尹星琪, 于彩果, 柯静, 赵冬, 于可. 2型糖尿病患者新型冠状病毒肺炎流行期间心理状态及行为调查[J]. 首都医科大学学报, 2020, 41(6): 970-977.
[12]	颜岑, 罗小敏, 冯英梅. 胰高血糖素样肽1通过类血管生成因子4调节糖尿病db小鼠棕色脂肪活性的机制[J]. 首都医科大学学报, 2020, 41(2): 217-224.
[13]	朱晓蓉, 杨芳远, 卢晶, 曹曦, 杨光燃, 谢荣荣, 冯建萍, 杨金奎. 增殖期糖尿病视网膜病变的血清代谢组学研究[J]. 首都医科大学学报, 2020, 41(1): 1-7.
[14]	李彬, 崔丽梅, 吕纳强, 严晔华, 郑晓敏, 陶静, 刘翠平. 初诊2型糖尿病患者糖尿病肾病与幽门螺旋杆菌感染的关系[J]. 首都医科大学学报, 2020, 41(1): 27-30.
[15]	魏嘉洁, 矫杰, 周迎生. 2型糖尿病合并阻塞性睡眠呼吸暂停综合征的临床特征及其危险因素[J]. 首都医科大学学报, 2020, 41(1): 35-39.